HEALTH● LOWAug 19 · Aug 19, 2026, 7:45 AM
Scancell secures united kingdom clearance for late - stage melanoma trial
proactiveinvestors.co.uk · United Kingdom
Scancell has secured clearance in the United Kingdom to proceed with a late-stage clinical trial for melanoma. This represents a significant step in the development of new treatments for the disease.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapUnited Kingdom and nearby eventsMore from United KingdomLatest stories and threat level
More from United Kingdom
CONFLICT15h agoMI5 chief says Iran tries to attack military facilities in the United KingdomClarínMILITARY1d agoUnited Kingdom points to Iran after alleged plot at British air base operated by USClarínPOLITICS6d agoIn the United Kingdom, the Conservatives want to reconquer the English rightLe Figaro InternationalPOLITICS6d agoMalvinas: The Government fulfills its threat and requests precautionary measures against the United Kingdom before an international tribunalClarín
More in Health
HEALTH13m agoSPECIAL REPORT: Insecurity exposes Zamfara communities to recurring cholera outbreaksPremium TimesHEALTH1h agoAt NIFST AGM: NAFDAC DG charges food scientists on food safety, qualityVanguard NigeriaHEALTH1h agoAMR: FG warns of growing threat of drug-resistant infectionsVanguard NigeriaHEALTH1h agoUttar Pradesh MBBS doctors protest over pay disparity, pending salary arrears; announce work boycottThe Hindu